Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Charles River Laboratories International (NYSE:CRL) Rating Increased to Overweight at Barclays

Summary by americanbankingnews.com
Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. The firm presently has a $195.00 price target on the medical research company’s stock, up from […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

americanbankingnews.comamericanbankingnews.com

Charles River Laboratories International (NYSE:CRL) Rating Increased to Overweight at Barclays

Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. The firm presently has a $195.00 price target on the medical research company’s stock, up from […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

americanbankingnews.com broke the news in on Saturday, October 4, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Wilmington, Massachusetts icon

Wilmington, Massachusetts

News
For You
SearchBlindspotLocal